The Georgia Foundation for Physical Therapy is accepting applications for its 2026 Research Grant through November 1, 2026. The program supports scientifically based, clinically relevant research that evaluates physical therapy interventions or services, with priority for work that can inform clinical practice.
Funding and timing
GFPT grants are limited to a maximum of $10,000. Applications opened September 1, 2026 and are due November 1, 2026. The controlling public page does not publish an exact closing time or time zone. Award notification is expected by November 15, 2026, and funding may begin as early as December 1, 2026 after confirmed IRB approval. Funds must be used within a 24 month budget period.
Eligibility and project requirements
The principal investigator must be a member of APTA Georgia and must be a Georgia licensed physical therapist or physical therapist assistant, or have met eligibility for physical therapy licensure. Proposed research must evaluate the efficacy or quality of physical therapy interventions or services. Experimental, descriptive, correlational, survey, qualitative, and interventional methods may be considered. GFPT states that projects should be collaborative ventures involving two or more partner organizations or institutions.
Submission
Applicants must use the current GFPT Research Grant application and submit the completed application to info@gfptonline.org with the subject line specified by the Foundation for the November 1, 2026 cycle. The Foundation states that applicants will receive email confirmation after submission.
Atlas assessment
Atlas Opportunity Score: 82/100. N9+ Fit Score: 30/100, conditional and secondary. A legitimate role for the Nonagon N9+ device and platform would require a physical therapy research protocol in which its verified examination or physiologic data capabilities are scientifically relevant, IRB appropriate, and budget allowable. The program is not a direct Dr. Miltie or QC Healthcare vendor solicitation, and Atlas should not force a technology role into unrelated physical therapy research.